Testing effectiveness (Phase 2)Ended earlyNCT01920945
What this trial is testing
OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study
Who this might be right for
New Daily Persistent Headache
St. Luke's-Roosevelt Hospital Center 6